See up to 3 months of MDLN. The 7-day demo opens the 1M and 3M ranges and puts MDLN on your watchlist.
Start 7-day demoLatest MDLN insider trades
About Medline Inc. (MDLN)
The SEC lists Medline Inc. under CIK 0002046386, in surgical and medical instruments and apparatus. It is grouped with Health Care companies on this site. Its offering priced on 18 December 2025 and it trades on NASDAQ.
MDLN Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 12 | 32,934,513 | $1.15B |
| Grant or award | 2 | 851,919 | |
| Other acquisition / disposition | 3 | 1,500,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
MDLN insider transactions (Form 4)
8265 Form 4 filings on record, the earliest from Dec 20, 2025, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| GIC Private Ltd - 10% Owner | Open-market sale | Class A Common Stock | 7,816,987 | $35.15 | $274.77M | |
| GIC Private Ltd - 10% Owner | Open-market sale | Class A Common Stock | 2,570,999 | $35.35 footnote F1 | $90.88M | |
| GIC Private Ltd - 10% Owner | Open-market sale | Class A Common Stock | 7,146,941 | $34.33 | $245.35M | |
| GIC Private Ltd - 10% Owner | Open-market sale | Class A Common Stock | 1,688,690 | $35.78 footnote F4 | $60.42M | |
| GIC Private Ltd - 10% Owner | Open-market sale | Class A Common Stock | 2,088,987 | $35.05 | $73.22M | |
| GIC Private Ltd - 10% Owner | Open-market sale | Class A Common Stock | 7,183,013 | $35.05 | $251.76M | |
| ||||||
 James M. Boyle - Officer | Grant or award | Incentive Units of Medline Holdings, LP | 764,252 | - footnote F1 | - | |
| ||||||
 Stephen L. Miller - Officer | Grant or award | Incentive Units of Medline Holdings, LP | 87,667 | - footnote F1 | - | |
| ||||||
| GIC Private Ltd - 10% Owner | Open-market sale | Class A Common Stock | 1,500,000 | $35.80 | $53.70M | |
| GIC Private Ltd - 10% Owner | Open-market sale | Class A Common Stock | 100,000 | $35.80 | $3.58M | |
| GIC Private Ltd - 10% Owner | Open-market sale | Class A Common Stock | 590,284 | $35.58 footnote F1 | $21.00M | |
| ||||||
| Mozart Holdco, Inc. - 10% Owner | Other | Class A Common Stock | 500,000 | $0.00 footnote F1 | - | |
| Mozart Holdco, Inc. - 10% Owner | Other | Class B Common Stock | 500,000 footnote F2 | $0.00 footnote F1 | - | |
| Mozart Holdco, Inc. - 10% Owner | Other | Common Units of Medline Holdings, LP | 500,000 | $0.00 footnote F1 | - | |
| ||||||
| GIC Private Ltd - 10% Owner | Open-market sale | Class A Common Stock | 1,710,907 | $35.46 footnote F1 | $60.67M | |
| GIC Private Ltd - 10% Owner | Open-market sale | Class A Common Stock | 265,711 | $36.48 footnote F3 | $9.69M | |
| GIC Private Ltd - 10% Owner | Open-market sale | Class A Common Stock | 271,994 | $35.33 footnote F4 | $9.61M | |
| ||||||
 William J. Abrams - Officer | Tax withholding / forfeiture | Class A Common Stock | 1,308 | $36.61 | $48K | |
 Christopher P. Shryock - Officer | Tax withholding / forfeiture | Class A Common Stock | 872 | $36.61 | $32K | |
| Stephen L. Miller - Officer | Tax withholding / forfeiture | Class A Common Stock | 1,889 | $36.61 | $69K | |
| Alexander M. Liberman - Officer | Tax withholding / forfeiture | Class A Common Stock | 872 | $36.61 | $32K | |
 Amanda H. Laabs - Officer | Tax withholding / forfeiture | Class A Common Stock | 1,889 | $36.61 | $69K | |
| Michael B. Drazin - Officer | Tax withholding / forfeiture | Class A Common Stock | 1,889 | $36.61 | $69K | |
| Douglas P. Golwas - Officer | Derivative | Class B Common Stock | 100,000 | - footnote F6 | - | |
| Douglas P. Golwas - Officer | Option exercise | Common Units of Medline Holdings, LP | 100,000 | $0.00 | - | |
| Douglas P. Golwas - Officer | Tax withholding / forfeiture | Class A Common Stock | 1,889 | $36.61 | $69K | |
| Douglas P. Golwas - Officer | Option exercise | Class A Common Stock | 100,000 | - footnote F2 | - | |
| Douglas P. Golwas - Officer | Open-market sale | Class A Common Stock | 61,966 | $36.60 footnote F4 | $2.27M | |
| Douglas P. Golwas - Officer | Open-market sale | Class A Common Stock | 38,034 | $37.05 footnote F5 | $1.41M | |
| ||||||
| James M. Boyle - Officer | Tax withholding / forfeiture | Class A Common Stock | 2,370 | $36.61 | $87K | |
 Richard A. Galanti | Grant or award | Class A Common Stock | 11,005 | - footnote F1 | - | |
| Richard A. Galanti | Grant or award | Class A Common Stock | 5,387 | $0.00 | - | |
| ||||||
| Thomas W. Sweet | Grant or award | Class A Common Stock | 12,413 | - footnote F1 | - | |
| Thomas W. Sweet | Grant or award | Class A Common Stock | 5,387 | $0.00 | - | |
| ||||||
 Todd M. Bluedorn | Grant or award | Class A Common Stock | 10,345 | $0.00 | - | |
| Todd M. Bluedorn | Grant or award | Class A Common Stock | 5,387 | $0.00 | - | |
| Jessi L. Corcoran - Officer | Open-market purchase | Class A Common Stock | 5,000 | $34.15 | $171K | |
| Hellman & Friedman Capital Partners X (Parallel), L.P. | Open-market sale | Class A Common Stock | 17,947,337 | $36.54 footnote F1 | $655.75M | |
| Hellman & Friedman Capital Partners X (Parallel), L.P. | Open-market sale | Class A Common Stock | 753,528 | $36.54 footnote F1 | $27.53M | |
| Hellman & Friedman Capital Partners X (Parallel), L.P. | Open-market sale | Class A Common Stock | 11,904,646 | $36.54 footnote F1 | $434.97M | |
| Hellman & Friedman Capital Partners X (Parallel), L.P. | Open-market sale | Class A Common Stock | 1,262,726 | $36.54 footnote F1 | $46.14M | |
| Hellman & Friedman Capital Partners X (Parallel), L.P. | Other | Class A Common Stock | 209,530 | - footnote F4 | - | |
| Hellman & Friedman Capital Partners X (Parallel), L.P. | Other | Class A Common Stock | 1,536,907 | - footnote F4 | - | |
| Hellman & Friedman Capital Partners X (Parallel), L.P. | Other | Class A Common Stock | 141,364 | - footnote F4 | - | |
| ||||||
| Patrick J. Healy | Other | Class A Common Stock | 179,762 | - footnote F1 | - | |
| Patrick J. Healy | Other | Class A Common Stock | 22,344 | - footnote F1 | - | |
| ||||||
| BCP 8 Holdings Mozart Manager L.L.C. | Open-market sale | Class A Common Stock | 19,712,326 | $36.54 footnote F1 | $720.24M | |
| BCP 8 Holdings Mozart Manager L.L.C. | Open-market sale | Class A Common Stock | 9,858,774 | $36.54 footnote F1 | $360.21M | |
| BCP 8 Holdings Mozart Manager L.L.C. | Open-market sale | Class A Common Stock | 2,256,800 | $36.54 footnote F1 | $82.46M | |
| BCP 8 Holdings Mozart Manager L.L.C. | Open-market sale | Class A Common Stock | 1,489,924 | $36.54 footnote F1 | $54.44M | |
| BCP 8 Holdings Mozart Manager L.L.C. | Other | Class A Common Stock | 438,214 | - footnote F9 | - | |
| ||||||
| BX Mozart ML-2 Holdco L.P. | Open-market sale | Class A Common Stock | 19,712,326 | $36.54 footnote F1 | $720.24M | |
| BX Mozart ML-2 Holdco L.P. | Open-market sale | Class A Common Stock | 9,858,774 | $36.54 footnote F1 | $360.21M | |
| BX Mozart ML-2 Holdco L.P. | Open-market sale | Class A Common Stock | 2,256,800 | $36.54 footnote F1 | $82.46M | |
| BX Mozart ML-2 Holdco L.P. | Open-market sale | Class A Common Stock | 1,489,924 | $36.54 footnote F1 | $54.44M | |
| BX Mozart ML-2 Holdco L.P. | Other | Class A Common Stock | 438,214 | - footnote F9 | - | |
| ||||||
| BX Mozart ML-1 Holdco L.P. | Other | Class A Common Stock | 9,858,774 | - footnote F1 | - | |
| BX Mozart ML-1 Holdco L.P. | Other | Class A Common Stock | 1,489,924 | - footnote F1 | - | |
| BX Mozart ML-1 Holdco L.P. | Other | Class B Common Stock | 9,858,774 | - footnote F10 | - | |
| BX Mozart ML-1 Holdco L.P. | Other | Class B Common Stock | 1,489,924 | - footnote F10 | - | |
| BX Mozart ML-1 Holdco L.P. | Other | Common Units of Medline Holdings, LP | 9,858,774 | $0.00 | - | |
| BX Mozart ML-1 Holdco L.P. | Other | Common Units of Medline Holdings, LP | 1,489,924 | $0.00 | - | |
| ||||||
| BCP 8 Holdings Mozart Manager L.L.C. | Other | Class A Common Stock | 9,858,774 | - footnote F1 | - | |
| BCP 8 Holdings Mozart Manager L.L.C. | Other | Class A Common Stock | 1,489,924 | - footnote F1 | - | |
| BCP 8 Holdings Mozart Manager L.L.C. | Other | Class B Common Stock | 9,858,774 | - footnote F10 | - | |
| BCP 8 Holdings Mozart Manager L.L.C. | Other | Class B Common Stock | 1,489,924 | - footnote F10 | - | |
| BCP 8 Holdings Mozart Manager L.L.C. | Other | Common Units of Medline Holdings, LP | 9,858,774 | $0.00 | - | |
| BCP 8 Holdings Mozart Manager L.L.C. | Other | Common Units of Medline Holdings, LP | 1,489,924 | $0.00 | - | |
| ||||||
| Hellman & Friedman Capital Partners X (Parallel), L.P. | Other | Class A Common Stock | 18,156,867 | - footnote F1 | - | |
| Hellman & Friedman Capital Partners X (Parallel), L.P. | Other | Class B Common Stock | 18,156,867 | - footnote F5 | - | |
| Hellman & Friedman Capital Partners X (Parallel), L.P. | Other | Common Units | 18,156,867 | - footnote F1 | - | |
| ||||||
| Patrick J. Healy | Other | Class A Common Stock | 507,844 | - footnote F1 | - | |
| Patrick J. Healy | Other | Class A Common Stock | 69,666 | - footnote F1 | - | |
| ||||||
| Hellman & Friedman Capital Partners X (Parallel), L.P. | Open-market sale | Class A Common Stock | 14,639,754 | $40.51 footnote F1 | $593.03M | |
| Hellman & Friedman Capital Partners X (Parallel), L.P. | Open-market sale | Class A Common Stock | 629,933 | $40.51 footnote F1 | $25.52M | |
| Hellman & Friedman Capital Partners X (Parallel), L.P. | Open-market sale | Class A Common Stock | 9,801,455 | $40.51 footnote F1,F4 | $397.04M | |
| Hellman & Friedman Capital Partners X (Parallel), L.P. | Open-market sale | Class A Common Stock | 1,060,095 | $40.51 footnote F1,F4 | $42.94M | |
| Hellman & Friedman Capital Partners X (Parallel), L.P. | Other | Class A Common Stock | 538,997 | - footnote F5 | - | |
| Hellman & Friedman Capital Partners X (Parallel), L.P. | Other | Class A Common Stock | 1,435,395 | - footnote F5 | - | |
| Hellman & Friedman Capital Partners X (Parallel), L.P. | Other | Class A Common Stock | 113,694 | - footnote F5 | - | |
| ||||||
| Carlyle Group Inc. - 10% Owner | Other | Class A Common Stock | 2,113,483 footnote F5 | - footnote F5 | - | |
| Carlyle Group Inc. - 10% Owner | Open-market sale | Class A Common Stock | 26,105,840 footnote F1 | $41.00 | $1.07B | |
| ||||||
Item 2.02, 9.01
Item 5.02
Item 5.07
Item 1.01, 2.03, 8.01, 9.01
Recent MDLN Form 144 notices of proposed sale
1An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
MDLN insider trading FAQ
What is the latest insider trade for MDLN?
Medline Inc. (MDLN) had 8 insider filings in the last 90 days, with the most recent on 2026-10-13. The full record for MDLN runs to 65 Form 4 filings, the earliest from 2025-12-20. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying MDLN stock?
No insider purchases of MDLN were filed in the last 90 days. 5 purchases are on record for this company.
How many insiders are selling MDLN stock?
12 insider sales of MDLN were filed in the last 90 days, totaling $1.15B.
Where can I see MDLN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects MDLN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - GIC Private Ltd view on EDGAR
- - GIC Private Ltd view on EDGAR
- - James M. Boyle view on EDGAR
- - Stephen L. Miller view on EDGAR
- - GIC Private Ltd view on EDGAR
- - GIC Private Ltd view on EDGAR
- - Mozart Holdco, Inc. view on EDGAR
- - GIC Private Ltd view on EDGAR
- - William J. Abrams view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where MDLN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow MDLN with a 7-day demo
- MDLN on your watchlist
- Every MDLN Form 4 filing on record
- Up to 3 months of MDLN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
